Elutia, Inc. (AZYO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1242310,
    "name": "Elutia, Inc.",
    "stock_name": "Elutia, Inc.",
    "full_name": "Elutia, Inc.",
    "name_url": "stocks-analysis/elutia-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.69",
    "chg": 0.05,
    "chgp": "7.35%",
    "dir": 1,
    "prev_price": "0.65",
    "mcapval": "79.70",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US05479K1060",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.42 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/elutia-inc-1242310-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Elutia, Inc. Stock Plummets to New 52-Week Low of $0.98",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elutia-inc-stock-plummets-to-new-52-week-low-of-098-3574506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElutiaInc_priceRelatedfactors_3574506.png",
        "date": "2025-09-26 15:15:11",
        "description": "Elutia, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a difficult year with a significant stock price decline. The company faces challenges, including negative financial metrics, declining net sales, and substantial operating losses, raising concerns about its market position."
      },
      {
        "title": "Elutia, Inc. Stock Plummets to New 52-Week Low of $1.03",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elutia-inc-stock-plummets-to-new-52-week-low-of-103-3571357",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElutiaInc_priceRelatedfactors_3571357.png",
        "date": "2025-09-25 16:50:07",
        "description": "Elutia, Inc., a microcap pharmaceutical company, has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. With a market cap of around USD 80 million, the company faces financial challenges, including negative EBITDA and declining sales, indicating potential instability and weak growth prospects."
      },
      {
        "title": "Elutia, Inc. Stock Plummets to New 52-Week Low of $1.06",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elutia-inc-stock-plummets-to-new-52-week-low-of-106-3552704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElutiaInc_priceRelatedfactors_3552704.png",
        "date": "2025-09-22 18:22:59",
        "description": "Elutia, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including negative cash flow and declining sales, raising concerns about its long-term viability in the industry."
      },
      {
        "title": "Is Elutia, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-elutia-inc-technically-bullish-or-bearish-3547721",
        "imagepath": "",
        "date": "2025-09-20 20:01:35",
        "description": "As of 9 September 2025, the technical trend for Elutia, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both the weekly and monthly time frames, bearish Bollinger Bands, and bearish moving averages on the daily chart. Additionally, Dow Theory indicates a bearish trend on both weekly and monthly scales. The KST shows a mildly bullish signal on the weekly but is bearish monthly, while OBV is mildly bearish on both time frames. \n\nElutia, Inc. has significantly underperformed compared to the S&P 500, with a year-to-date return of -71.12% versus the S&P 500's 12.22%, and a one-year return of -72.02% compared to 17.14% for the index...."
      },
      {
        "title": "Is Elutia, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-elutia-inc-overvalued-or-undervalued-3544009",
        "imagepath": "",
        "date": "2025-09-20 18:35:01",
        "description": "As of 1 March 2021, Elutia, Inc. has moved from a grade of does not qualify to risky, indicating an increased perception of potential investment risk. The company appears to be overvalued based on its negative valuation ratios, including a Price to Book Value of -2.14, an EV to EBIT of -4.17, and an EV to EBITDA of -4.91. These metrics suggest that the company is struggling financially, particularly in comparison to its peers, such as Catalyst Biosciences, Inc. with a P/E of 110.04 and Pluri, Inc. with a P/E of -1.72.\n\nElutia's recent stock performance has been significantly poor, with a year-to-date return of -71.12% compared to the S&P 500's gain of 12.22%. This stark contrast reinforces the notion that Elutia, Inc. is overvalued in its current state...."
      },
      {
        "title": "Elutia, Inc. Stock Plummets to New 52-Week Low of $1.08",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elutia-inc-stock-plummets-to-new-52-week-low-of-108-3537149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElutiaInc_priceRelatedfactors_3537149.png",
        "date": "2025-09-19 13:12:23",
        "description": "Elutia, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including negative book value, declining net sales, and substantial operating losses, raising concerns about its long-term viability."
      },
      {
        "title": "Elutia, Inc. Stock Plummets to New 52-Week Low of $1.13",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elutia-inc-stock-plummets-to-new-52-week-low-of-113-3531553",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElutiaInc_priceRelatedfactors_3531553.png",
        "date": "2025-09-18 13:23:58",
        "description": "Elutia, Inc., a microcap pharmaceutical company, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company operates at a loss, has a negative book value, and faces difficulties with declining net sales and poor financial metrics, including negative operating cash flow."
      },
      {
        "title": "Elutia, Inc. Stock Plummets to New 52-Week Low of $1.17",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/elutia-inc-stock-plummets-to-new-52-week-low-of-117-3519649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ElutiaInc_priceRelatedfactors_3519649.png",
        "date": "2025-09-16 11:32:00",
        "description": "Elutia, Inc., a microcap pharmaceutical company, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including negative operating cash flow and declining net sales, indicating struggles with long-term growth and market position."
      }
    ],
    "total": 13,
    "sid": "1242310",
    "stock_news_url": "https://www.marketsmojo.com/news/elutia-inc-1242310"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Elutia, Inc. Stock Plummets to New 52-Week Low of $0.98

2025-09-26 15:15:11

Elutia, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a difficult year with a significant stock price decline. The company faces challenges, including negative financial metrics, declining net sales, and substantial operating losses, raising concerns about its market position.

Elutia, Inc. Stock Plummets to New 52-Week Low of $1.03

2025-09-25 16:50:07

Elutia, Inc., a microcap pharmaceutical company, has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. With a market cap of around USD 80 million, the company faces financial challenges, including negative EBITDA and declining sales, indicating potential instability and weak growth prospects.

Elutia, Inc. Stock Plummets to New 52-Week Low of $1.06

2025-09-22 18:22:59

Elutia, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including negative cash flow and declining sales, raising concerns about its long-term viability in the industry.

Is Elutia, Inc. technically bullish or bearish?

2025-09-20 20:01:35

As of 9 September 2025, the technical trend for Elutia, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both the weekly and monthly time frames, bearish Bollinger Bands, and bearish moving averages on the daily chart. Additionally, Dow Theory indicates a bearish trend on both weekly and monthly scales. The KST shows a mildly bullish signal on the weekly but is bearish monthly, while OBV is mildly bearish on both time frames. Elutia, Inc. has significantly underperformed compared to the S&P 500, with a year-to-date return of -71.12% versus the S&P 500's 12.22%, and a one-year return of -72.02% compared to 17.14% for the index....

Is Elutia, Inc. overvalued or undervalued?

2025-09-20 18:35:01

As of 1 March 2021, Elutia, Inc. has moved from a grade of does not qualify to risky, indicating an increased perception of potential investment risk. The company appears to be overvalued based on its negative valuation ratios, including a Price to Book Value of -2.14, an EV to EBIT of -4.17, and an EV to EBITDA of -4.91. These metrics suggest that the company is struggling financially, particularly in comparison to its peers, such as Catalyst Biosciences, Inc. with a P/E of 110.04 and Pluri, Inc. with a P/E of -1.72. Elutia's recent stock performance has been significantly poor, with a year-to-date return of -71.12% compared to the S&P 500's gain of 12.22%. This stark contrast reinforces the notion that Elutia, Inc. is overvalued in its current state....

Elutia, Inc. Stock Plummets to New 52-Week Low of $1.08

2025-09-19 13:12:23

Elutia, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including negative book value, declining net sales, and substantial operating losses, raising concerns about its long-term viability.

Elutia, Inc. Stock Plummets to New 52-Week Low of $1.13

2025-09-18 13:23:58

Elutia, Inc., a microcap pharmaceutical company, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company operates at a loss, has a negative book value, and faces difficulties with declining net sales and poor financial metrics, including negative operating cash flow.

Elutia, Inc. Stock Plummets to New 52-Week Low of $1.17

2025-09-16 11:32:00

Elutia, Inc., a microcap pharmaceutical company, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including negative operating cash flow and declining net sales, indicating struggles with long-term growth and market position.

View All News